Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Envigo has announced that its breeding facilities in Bresso, Italy and Wyton, UK have been granted full accreditation from the Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC) International Council.
read more
Monday, February 01, 2016
Gilead Sciences has announced that, effective March 10, 2016, current Chairman and CEO John C. Martin, PhD will assume the role of Executive Chairman of the company. John F. Milligan, PhD, currently President and Chief Operating Officer, will be ...
read more
Wednesday, August 03, 2016
Eurofins Scientific has announced the appointment of Kally Probasco, President, Eurofins Microbiology Laboratory (EML).
read more
Wednesday, December 14, 2016
Recipharm has appointed Anders Högdin and Aaron Small to lead the growth of its pharmaceutical development services business in the US and Europe.
read more
Wednesday, November 08, 2017
Velesco announced the award of a subcontract for analytical method development, manufacturing clinical supplies, and testing the stability of an investigational drug for the treatment for Beta-Thalassemia.
read more
Wednesday, February 14, 2018
Additional resources will help advance initiatives to support novel medical technology and public health priorities such as generic drug development, pharmacy outsourcing and novel domestic manufacturing capabilities.
read more
Tuesday, October 17, 2023
Vetter has announced additional investments as part of its long-term dedication to customer partnerships. Vetter’s extensive 40+ years of experience in aseptic filling and packaging shows a consistent desire for sustainable growth and corporate ...
read more
VAI has partnered with Adents to provide its pharmaceutical customers with a complete solution to meet upcoming requirements under the Drug Supply Chain Security Act (DSCSA).
read more
Thursday, February 27, 2020
Latham BioPharm Group announced the recent addition of Dr. Thijs Beuming to the team to lead In Silico Drug Discovery services.
read more
Wednesday, September 23, 2015
The FDA has approved trifluridine/tipiracil for the treatment of patients with metastatic colorectal cancer who have been previously treated with fluoropyrimidine-, oxaliplatin- , and irinotecan-based chemotherapy, an anti-VEGF biologic product, and ...
read more
Wednesday, April 20, 2016
PCI Synthesis, Inc. has announced the formation of its cGMP Advanced Polymer Development and Manufacturing Group, which is currently developing and manufacturing more than a dozen advanced polymer-based projects.
read more
Saturday, September 25, 2021
Republic of South Korea based Genome and Company has entered into agreements subject to regulatory approval to acquire controlling interest in U.S. based List Biological Laboratories, Inc. (List Labs). The resulting partnership creates the first ...
read more
Thursday, October 23, 2025
AGC Biologics has entered into an agreement with Rarity PBC to develop and manufacture RDP-101, a breakthrough gene therapy targeting Adenosine Deaminase Severe Combined Immunodeficiency Disorder (ADA-SCID), also known as “Bubble Baby Disease”.
read more
Ashland completed the expansion of its Viatel bioresorbable polymer manufacturing site and has relocated R&D from Dublin to the National Science Park, Ireland.
read more
Particle Sciences, Inc. has expanded its development
capabilities to accommodate the increasing demand for biopharmaceutical formulation and
analysis. According to Robert Becker, Vice President Biopharmaceutical Sales and Business
Development ...
read more